Scholar Rock Ownership | Who Owns Scholar Rock?
Scholar Rock Ownership Summary
Scholar Rock is owned by 13.11% institutional investors, 0.76% insiders, and 86.13% retail investors. Fmr is the largest institutional shareholder, holding 15.03% of SRRK shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.86% of its assets in Scholar Rock shares.
SRRK Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Scholar Rock | 13.11% | 0.76% | 86.13% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 17.24M | 15.03% | $847.67M |
| Artal group | 11.26M | 11.74% | $93.79M |
| Siren | 10.83M | 9.44% | $532.16M |
| Redmile group | 9.07M | 7.90% | $445.72M |
| Blackrock funding, inc. /de | 7.47M | 6.51% | $367.19M |
| Samsara biocapital | 6.90M | 6.01% | $339.09M |
| Blackrock | 5.66M | 5.91% | $47.18M |
| Wellington management group llp | 6.72M | 5.86% | $330.24M |
| Price t rowe associates inc /md/ | 6.21M | 5.41% | $305.12M |
| Vanguard group | 5.20M | 4.57% | $228.86M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Samsara biocapital | 6.90M | 32.95% | $339.09M |
| Redmile group | 9.07M | 29.51% | $445.72M |
| Siren | 10.83M | 14.75% | $532.16M |
| Stempoint capital lp | 1.04M | 9.89% | $50.90M |
| Fairmount funds management | 1.82M | 6.11% | $67.93M |
| Eagle health investments lp | 494.02K | 4.25% | $24.29M |
| Bellevue group | 3.58M | 4.19% | $176.22M |
| First turn management | 446.39K | 2.45% | $21.94M |
| Artal group | 11.26M | 2.39% | $93.79M |
| Rock springs capital management lp | 739.82K | 2.14% | $36.37M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Redmile group | 9.07M | 29.51% | 3.85M |
| Norges bank | 2.08M | 0.01% | 2.08M |
| Fmr | 17.24M | 0.04% | 1.86M |
| Wellington management group llp | 6.72M | 0.06% | 958.23K |
| Point72 asset management | 1.01M | 0.06% | 874.38K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | 1.23M | 1.23% | -1.84M |
| Commodore capital lp | - | - | -1.45M |
| Nationale-nederlanden powszechne towarzystwo emerytalne | - | - | -769.44K |
| Bellevue group | 3.58M | 4.19% | -472.02K |
| Bioimpact capital | - | - | -416.14K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 2.08M | 0.01% | 2.08M | $91.60M |
| Vanguard fiduciary trust | 589.05K | 0.01% | 589.05K | $28.96M |
| Logos global management lp | 175.00K | 0.58% | 175.00K | $6.52M |
| Cinctive capital management lp | 172.53K | 0.55% | 172.53K | $8.48M |
| Axa investment managers | 132.57K | 0.01% | 132.57K | $4.94M |
Sold Out
| Holder | Change |
|---|---|
| Hughes financial services | -1.00 |
| Natixis | -3.00 |
| Concord wealth partners | -5.00 |
| Td private client wealth | -9.00 |
| Principal securities | -9.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 116 | -59.86% | 15,034,927 | -87.83% | 13 | 0.11% | 52 | -70.29% | 35 | -49.28% |
| Dec 31, 2025 | 212 | -21.48% | 67,775,501 | -41.57% | 59 | 0.56% | 120 | -18.37% | 56 | -11.11% |
| Sep 30, 2025 | 265 | 7.29% | 114,678,020 | 4.47% | 101 | 1.07% | 143 | 7.52% | 63 | -8.70% |
| Jun 30, 2025 | 244 | 2.09% | 109,732,730 | 6.85% | 97 | 1.15% | 131 | 6.50% | 68 | -1.45% |
| Mar 31, 2025 | 240 | -5.88% | 104,870,614 | 0.44% | 93 | 0.81% | 124 | -21.52% | 70 | 16.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 5.78M | 4.86% | 307.50K |
| Fidelity Growth Compy Commingled Pl O | 3.59M | 4.49% | 36.80K |
| Fidelity Growth Company Fund | 4.15M | 3.48% | 257.11K |
| BB Biotech AG Ord | 3.24M | 3.17% | 305.67K |
| Vanguard Health Care Inv | 3.68M | 3.09% | 928.77K |
| Vanguard US Total Market Shares ETF | 2.29M | 2.42% | - |
| Vanguard Total Stock Mkt Idx Inv | 2.80M | 2.34% | 8.03K |
| State Street® SPDR® S&P® Biotech ETF | 2.19M | 1.83% | -21.65K |
| iShares Russell 2000 ETF | 2.05M | 1.72% | 17.30K |
| T. Rowe Price New Horizons | 1.86M | 1.62% | 12.37K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 16, 2026 | Woods Keith | Chief Operating Officer | Sell | $506.65K |
| Apr 16, 2026 | Vaishnaw Akshay | President of R&D | Sell | $607.09K |
| Apr 16, 2026 | Sinha Vikas | Chief Financial Officer | Sell | $516.07K |
| Apr 16, 2026 | Hallal David | Chief Executive Officer | Sell | $1.52M |
| Feb 23, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Sell | $9.70K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 4 |
| 2026 Q1 | - | 18 |
| 2025 Q4 | 9 | 3 |
| 2025 Q3 | - | 7 |
| 2025 Q2 | - | 22 |
SRRK Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools